Metabolic Disorders in Multiple Myeloma
Multiple myeloma (MM) is the second most common hematological malignancy and is attributed to monoclonal proliferation of plasma cells in the bone marrow. Cancer cells including myeloma cells deregulate metabolic pathways to ensure proliferation, growth, survival and avoid immune surveillance, with...
Guardado en:
Autores principales: | Maria Gavriatopoulou, Stavroula A. Paschou, Ioannis Ntanasis-Stathopoulos, Meletios A. Dimopoulos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09e31b8548c4455aae403a9d8e95af86 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advances in improving mammalian cells metabolism for recombinant protein production
por: Altamirano,Claudia, et al.
Publicado: (2013) -
Nitric Oxide Circumvents Virus-Mediated Metabolic Regulation during Human Cytomegalovirus Infection
por: Rebekah L. Mokry, et al.
Publicado: (2020) -
Expression of STOML2 promotes proliferation and glycolysis of multiple myeloma cells via upregulating PAI-1
por: Hongxia Zhang, et al.
Publicado: (2021) -
Macroglossia reveals multiple myeloma
por: Maria Bonvicini, et al.
Publicado: (2021) -
IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
por: E. A. Senkina, et al.
Publicado: (2014)